Cannabis-based Medicine for Pain in Traumatic Brachial Plexus Injury: A Triple-blinded, Crossover, Randomized Controlled Trial
Phase 4
Completed
- Conditions
- Pain/Neuropathic pain in brachial plexus injury which cannot be controlled by conventional analgesic medicationsCannabis, neuropathic pain, brachial plexus injury
- Registration Number
- TCTR20191106004
- Lead Sponsor
- erdsin Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1. Patient with traumatic brachial plexus injury who fail conventional analgesic medication in appropriate dosage (Moderate to severe pain)
2. Age Between 20-60 years
3. No previous history of cannabis usage before
Exclusion Criteria
1. Previous allergy history of cannabis or its derivative
2. Unstable cardio-pulmonary disease or risk of ischemic heart disease
3. Previous history of psychosis, concurrent active mood disorder or anxiety disorder
4. Pregnant woman, current breast feeding woman, woman who plan to have child or not use the contraceptive
5. Patient who concurrent use of medication which may altered by cannabis such as Warfarin, Clobazam, Fluoroquinolones, Dihydropyridines group
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VIsual analogue score for pain Before intervenion, each day in intervention time Visual analogue acore
- Secondary Outcome Measures
Name Time Method europathic pain Before intervenion, each day in intervention time DN4 questionnaire,Sleep quality each day of intervention VAS